The British newspaper, “Metro”, said, “Sleepio” application offers a six-week digital treatment program using an artificial intelligence (AI) algorithm, in which the application provides customized cognitive behavioral therapy for insomnia (CBT-I).
The Sleeppio app will save NHS money as well as reduce prescribing of medicines such as Zolpidem and Zopiclone.
The app, which costs £45 per person, also offers a digital self-help program that includes a sleep test, weekly interactive CBT-I sessions and a sleep diary.
Cognitive behavioral therapy (CBT-I) sessions will focus on identifying the thoughts, feelings, and behaviors that contribute to insomnia symptoms. Cognitive interventions aim to improve the way a person thinks about sleep. Behavioral interventions aim to promote a healthy sleep routine.
The program is designed to be completed in six weeks, but people have full access to it for 12 months of registration, so people can complete sessions at their own pace.
People can use the app's daily sleep diary to track their progress based on personalized advice, and users can fill in the diary manually or the data can be automatically uploaded from a compatible wearable tracker, such as an Apple Watch or Fitbit.
Patients can also access e-library articles, online tools, and join the online Sleepio user community for support.
Clinical evidence submitted to the National Institute for Health and Care Excellence (NICE) from 12 randomized controlled trials showed that Sleepio was more effective in reducing insomnia than sleep hygiene and sleeping pills.
An economic analysis also found that one-year Sleepio use reduced healthcare beds, mostly due to fewer GP appointments and prescribed sleeping pills.
“So far, people with insomnia have been offered sleeping pills and taught about sleep hygiene, so our committee’s recommendation for Sleepio offers GPs and their patients a new treatment option,” said Janet Cosell, MedTech Director and Digital in Nice.